181 related articles for article (PubMed ID: 29787800)
1. The effect of formulation on spray dried Sabin inactivated polio vaccine.
Kanojia G; Ten Have R; Brugmans D; Soema PC; Frijlink HW; Amorij JP; Kersten G
Eur J Pharm Biopharm; 2018 Aug; 129():21-29. PubMed ID: 29787800
[TBL] [Abstract][Full Text] [Related]
2. Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.
Shin WJ; Hara D; Gbormittah F; Chang H; Chang BS; Jung JU
mBio; 2018 Nov; 9(6):. PubMed ID: 30482835
[TBL] [Abstract][Full Text] [Related]
3. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
Crawt L; Atkinson E; Tedcastle A; Pegg E; ; Minor P; Cooper G; Rigsby P; Martin J
J Infect Dis; 2020 Feb; 221(4):544-552. PubMed ID: 30788503
[TBL] [Abstract][Full Text] [Related]
4. Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array.
Wan Y; Hickey JM; Bird C; Witham K; Fahey P; Forster A; Joshi SB; Volkin DB
J Pharm Sci; 2018 Jun; 107(6):1540-1551. PubMed ID: 29421219
[TBL] [Abstract][Full Text] [Related]
5. Design and Optimization of a Temperature-Stable Dry Powder BCG Vaccine.
Price DN; Kunda NK; Ellis R; Muttil P
Pharm Res; 2019 Dec; 37(1):11. PubMed ID: 31873825
[TBL] [Abstract][Full Text] [Related]
6. Development of thermostable lyophilized inactivated polio vaccine.
Kraan H; van Herpen P; Kersten G; Amorij JP
Pharm Res; 2014 Oct; 31(10):2618-29. PubMed ID: 24760448
[TBL] [Abstract][Full Text] [Related]
7. A national reference for inactivated polio vaccine derived from Sabin strains in Japan.
Shirato H; Someya Y; Ochiai M; Horiuchi Y; Takahashi M; Takeda N; Wakabayashi K; Ouchi Y; Ota Y; Tano Y; Abe S; Yamazaki S; Wakita T;
Vaccine; 2014 Sep; 32(40):5163-9. PubMed ID: 25090648
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV).
Li Z; Ding W; Guo Q; Liu Z; Zhu Z; Song S; Li W; Liao G
Hum Vaccin Immunother; 2018; 14(8):1987-1994. PubMed ID: 29601259
[TBL] [Abstract][Full Text] [Related]
9. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.
Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C
J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813
[TBL] [Abstract][Full Text] [Related]
10. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time reducing and stability improving formulations.
Massant J; Fleurime S; Batens M; Vanhaerents H; Van den Mooter G
Eur J Pharm Biopharm; 2020 Nov; 156():131-142. PubMed ID: 32882422
[TBL] [Abstract][Full Text] [Related]
11. Acoustic levitation as a screening method for excipient selection in the development of dry powder vaccines.
Morgan BA; Xing Z; Cranston ED; Thompson MR
Int J Pharm; 2019 May; 563():71-78. PubMed ID: 30930189
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of HSV-2 viral vaccine candidate by spray drying.
LeClair DA; Li L; Rahman N; Cranston ED; Xing Z; Thompson MR
Int J Pharm; 2019 Oct; 569():118615. PubMed ID: 31415872
[TBL] [Abstract][Full Text] [Related]
13. Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats.
Murakami K; Fujii Y; Someya Y
Vaccine; 2020 Apr; 38(17):3295-3299. PubMed ID: 32197923
[TBL] [Abstract][Full Text] [Related]
14. Universal ELISA for quantification of D-antigen in inactivated poliovirus vaccines.
Kouiavskaia D; Puligedda RD; Dessain SK; Chumakov K
J Virol Methods; 2020 Feb; 276():113785. PubMed ID: 31765719
[TBL] [Abstract][Full Text] [Related]
15. Developments in the formulation and delivery of spray dried vaccines.
Kanojia G; Have RT; Soema PC; Frijlink H; Amorij JP; Kersten G
Hum Vaccin Immunother; 2017 Oct; 13(10):2364-2378. PubMed ID: 28925794
[TBL] [Abstract][Full Text] [Related]
16. Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying.
Gomez M; Archer M; Barona D; Wang H; Ordoubadi M; Bin Karim S; Carrigy NB; Wang Z; McCollum J; Press C; Gerhardt A; Fox CB; Kramer RM; Vehring R
Eur J Pharm Biopharm; 2021 Jun; 163():23-37. PubMed ID: 33753213
[TBL] [Abstract][Full Text] [Related]
17. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: stability of a vaccine.
Abdul-Fattah AM; Truong-Le V; Yee L; Pan E; Ao Y; Kalonia DS; Pikal MJ
Pharm Res; 2007 Apr; 24(4):715-27. PubMed ID: 17372697
[TBL] [Abstract][Full Text] [Related]
18. Comparison of melibiose and trehalose as stabilising excipients for spray-dried β-galactosidase formulations.
Lipiäinen T; Räikkönen H; Kolu AM; Peltoniemi M; Juppo A
Int J Pharm; 2018 May; 543(1-2):21-28. PubMed ID: 29567196
[TBL] [Abstract][Full Text] [Related]
19. Urea Improves Stability of Inactivated Polio Vaccine Serotype 3 During Lyophilization and Storage in Dried Formulations.
Qi W; Orgel S; Francon A; Randolph TW; Carpenter JF
J Pharm Sci; 2018 Aug; 107(8):2070-2078. PubMed ID: 29709487
[TBL] [Abstract][Full Text] [Related]
20. Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.
Murugappan S; Patil HP; Kanojia G; ter Veer W; Meijerhof T; Frijlink HW; Huckriede A; Hinrichs WL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):716-25. PubMed ID: 23933147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
